Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.96 USD | -2.54% | +17.05% | -1.57% |
02/05 | Transcript : Vir Biotechnology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
02/05 | Earnings Flash (VIR) VIR BIOTECHNOLOGY Reports Q1 Revenue $56.4M, vs. Street Est of $11.7M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.57% | 1.39B | |
+20.55% | 46.81B | |
-1.06% | 41.37B | |
+47.07% | 41.29B | |
-3.52% | 28.87B | |
+11.69% | 26.06B | |
-19.70% | 19.13B | |
+32.62% | 12.39B | |
+0.33% | 12.08B | |
-0.45% | 11.96B |
- Stock Market
- Equities
- VIR Stock
- News Vir Biotechnology, Inc.
- Morgan Stanley Initiates Vir Biotechnology at Underweight With $15 Price Target